| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 924,932 | 903,612 | 918,492 | 1,029,316 | | Cost of Revenue | 212,820 | 210,098 | 216,978 | 108,128 | | | Gross Profit | 712,112 | 693,514 | 701,514 | 921,188 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 70,529 | 69,587 | 67,946 | 201,140 | | Non Recurring |
-
| 140,478 |
-
| (17,367) | | Others | 230,070 | 258,751 | 269,352 | 292,937 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 392,177 | 224,698 | 364,216 | 444,478 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| (21,172) | | Earnings Before Interest And Taxes | 359,136 | 230,335 | 372,284 | 536,780 | | Interest Expense | 257,881 | 244,443 | 226,036 | 244,933 | | Income Before Tax | 101,255 | (14,108) | 146,248 | 291,847 | | Income Tax Expense | (238) | (143) | (2,523) | 2,005 | | Minority Interest |
-
|
-
|
-
| 92,712 | | | | Net Income From Continuing Ops | 59,676 | (14,108) | 146,248 | 288,266 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (25) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 59,676 | (14,108) | 146,248 | 288,241 | | Preferred Stock And Other Adjustments | 26,535 | (6,652) | (39,480) | (143,038) | | | Net Income Applicable To Common Shares | $105,547 | ($20,760) | $106,768 | $145,203 |
|
0.03% Nasdaq 
0.57 (0.69%) 
Income Statement
